Nuclear Medicine Imaging in Rheumatic Diseases
Author(s) -
Yun Young Choi,
Ji Young Kim
Publication year - 2017
Publication title -
journal of rheumatic diseases
Language(s) - English
Resource type - Journals
eISSN - 2093-940X
pISSN - 2233-4718
DOI - 10.4078/jrd.2017.24.1.4
Subject(s) - positron emission tomography , medicine , medical imaging , single photon emission computed tomography , bone imaging , emission computed tomography , rheumatic disease , medical physics , nuclear medicine imaging , nuclear medicine , radiology , preclinical imaging , tomography , computed tomography , nuclear imaging , modalities , disease , pathology , social science , microbiology and biotechnology , sociology , biology , in vivo
The rapid development of medical imaging technologies has greatly enhanced the utility of nuclear medicine imaging modalities over the last decade. Hybrid imaging technology merging computed tomography (CT) with single-photon emission computed tomography (SPECT) or positron emission tomography (PET) allows superimposing the physiologic data obtained by SPECT or PET on the detailed anatomy of CT, yielding a better understanding of the disease status and improving diagnostic performance. However, the conventional whole body bone scan and three phase bone scan still have their own distinct role as diagnostic imaging, reflecting the changes of bone metabolism in benign and malignant diseases, including rheumatic diseases. A review of each nuclear medicine imaging technique and clinical applications in various conditions of rheumatic diseases will be presented in this article. (J Rheum Dis 2017;24:4-13)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom